Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
EBITDA margin, % ? 32.6% -23.6% -2.59% -95.6% -41.0%   -40.5%  
Changes by years, y/y, % +43pp -56pp +21pp -93pp +55pp     +31.9%

Ionis Pharmaceuticals. EBITDA margin, %

Ionis Pharmaceuticals. EBITDA margin, changes, pp

Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2024Q1 2024Q2   LTM ?
EBITDA margin, % ? -31.4% -85.4% -0.51% -120.4% -26.9%   -40.5%
Changes by years, y/y, % +39pp -54pp +235pp -46pp +5pp    
Changes by quarters, q/q, % +43pp -54pp +85pp -120pp +94pp    

Ionis Pharmaceuticals. EBITDA margin, %

Ionis Pharmaceuticals. EBITDA margin, changes, pp

Ionis Pharmaceuticals. EBITDA margin, changes, pp